Early Detection, Better Outcomes: Addressing unmet needs in type 1 diabetes
The event, co-organised by the European Diabetes Forum (EUDF) and EDENT1FI, with support of the Danish Presidency of the Council of the European Union, will address the early diagnosis of type 1 diabetes, ongoing research and innovative approaches to treatment.
Date and time
Location
Refund policy
About this event
Join us on November 4 to discuss the early detection and disease-modifying therapies in type 1 diabetes. See below our full programme:
Welcome and opening statement
Welcome and perspective from the European Parliament
- MEP Stine Bosse, SANT Committee
The importance of a strong life sciences ecosystem
- Simone Overby Sloth, Counsellor for Health, Permanent Representation of Denmark to the EU
Early Diagnosis of Type 1 diabetes
Introduction to T1D and Early detection for T1D in Europe: EDENT1FI
- Prof. Dr. Chantal Mathieu, President EASD/EFSD, Vice-Chair EUDF, UZ Leuven
Learnings from Italy: best practice
- Prof. Dr. Emanuele Bosi, San Raffaele Hospital, Milan
Testimonials and thoughts from people living with T1D
Moderator: Jurgen Vercauteren, EDENT1FI Patient Advisory Committee
Panel:
- Maria Hartmann Tørnes and her 13-year-old daughter Cathrine
- Michaela Mervartová
- Francesca Ulivi
- Kirsten Jorsal
- MEP Niels Flemming Hansen
Research and early detection as a basis for early intervention and disease interception
Early detection of type 1 diabetes - the Scandinavian perspective
- Finn Kristensen, Program Director, DiaUnion
Driving European Competitiveness Through Health Research
- Dr Petra Goyens, Deputy Head of Combatting Diseases Unit, DG RTD EU Commission
IHI's model: how to build bold collaborations and put Europe at the forefront of T1D research
- Klelia Salpea, Scientific Officer, IHI
EUDF recommendations for clinical implementation of disease modifying therapies
- Carmen Hurtado del Pozo, Director European Research, Breakthrough T1D
Round table: EUDF recommendations for clinical implementation of disease modifying therapies
Moderator: Prof. Dr. Chantal Mathieu
Panel:
- Carmen Hurtado del Pozo, Director European Research, Breakthrough T1D
- Prof. Dr. Pieter Gillard, EASD
- Dr. Sufyan Hussain, IDF-Europe
- Luciana Gusukuma, Sanofi
- Maddy Farnworth, Novo Nordisk
Conclusion and Call to action
Call to action
- MEP Stine Bosse, SANT Committee
- Prof. Dr. Chantal Mathieu